Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening: "Today’s recommendations are an important acknowledgement of the role of Pap testing combined with HPV testing,
HPV testing preferred over Pap for cervical cancer screening starting at age 30, task force’s draft recommendation says
Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new draft recommendation from the US Preventive Services Task Force.
The bipartisan House task force -- investigating two assassination attempts on President-elect Donald Trump -- released its ...
In guidelines that may encourage more women to get screened for cervical cancer, a leading health task force has backed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback